C E Edmiston

Summary

Affiliation: Medical College of Wisconsin
Country: USA

Publications

  1. ncbi Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission?
    Charles E Edmiston
    Division of Vascular Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    J Am Coll Surg 207:233-9. 2008
  2. ncbi Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device
    Charles E Edmiston
    Surgical Microbiology Research Laboratory, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA
    Am J Infect Control 38:421-3. 2010
  3. ncbi Reducing the risk of surgical site infections: Does chlorhexidine gluconate provide a risk reduction benefit?
    Charles E Edmiston
    Department of Surgery, Medical College of Wisconsin, Milwaukee, WI Electronic address
    Am J Infect Control 41:S49-55. 2013
  4. ncbi Microbiology of explanted suture segments from infected and noninfected surgical patients
    Charles E Edmiston
    Surgical Microbiology Research Laboratory, College of Wisconsin, Milwaukee, Wisconsin, USA
    J Clin Microbiol 51:417-21. 2013
  5. ncbi Evaluation of an antimicrobial surgical glove to inactivate live human immunodeficiency virus following simulated glove puncture
    Charles E Edmiston
    Division of Vascular Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Surgery 153:225-33. 2013
  6. ncbi Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery
    Charles E Edmiston
    Division of Vascular Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
    Am J Infect Control 35:89-96. 2007
  7. ncbi Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices
    Charles E Edmiston
    Division of Vascular Surgery, Medical College of Wisconsin, 9200 West Wisconsin Ave, Milwaukee, WI 53226, USA
    Am J Surg 192:344-54. 2006
  8. ncbi Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients
    Charles E Edmiston
    Division of Vascular Surgery, Medical College of Wisconsin, Milwaukee, WI, USA
    J Antimicrob Chemother 56:872-8. 2005
  9. ncbi Tissue and fluid penetration of garenoxacin in surgical patients
    Charles E Edmiston
    Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Surg Infect (Larchmt) 8:179-88. 2007
  10. ncbi In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections
    Charles E Edmiston
    Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Antimicrob Agents Chemother 48:1012-6. 2004

Collaborators

Detail Information

Publications29

  1. ncbi Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission?
    Charles E Edmiston
    Division of Vascular Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    J Am Coll Surg 207:233-9. 2008
    ..In this study, chlorhexidine gluconate (CHG) skin concentrations were determined after preoperative showering/skin cleansing using 4% CHG soap or 2% CHG-impregnated polyester cloth...
  2. ncbi Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device
    Charles E Edmiston
    Surgical Microbiology Research Laboratory, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA
    Am J Infect Control 38:421-3. 2010
    ..The present in vitro study compares the antimicrobial property of a silver-nanotechnology LAD to 8 nonantimicrobial LADs...
  3. ncbi Reducing the risk of surgical site infections: Does chlorhexidine gluconate provide a risk reduction benefit?
    Charles E Edmiston
    Department of Surgery, Medical College of Wisconsin, Milwaukee, WI Electronic address
    Am J Infect Control 41:S49-55. 2013
    ....
  4. ncbi Microbiology of explanted suture segments from infected and noninfected surgical patients
    Charles E Edmiston
    Surgical Microbiology Research Laboratory, College of Wisconsin, Milwaukee, Wisconsin, USA
    J Clin Microbiol 51:417-21. 2013
    ..Further studies to document the benefit of focused risk reduction strategies to minimize suture contamination and biofilm formation postimplantation are warranted...
  5. ncbi Evaluation of an antimicrobial surgical glove to inactivate live human immunodeficiency virus following simulated glove puncture
    Charles E Edmiston
    Division of Vascular Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Surgery 153:225-33. 2013
    ..This study evaluated the efficacy of an innovative integrated antimicrobial glove to reduce transmission of the human immunodeficiency virus (HIV) following a simulated surgical-glove puncture injury...
  6. ncbi Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery
    Charles E Edmiston
    Division of Vascular Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
    Am J Infect Control 35:89-96. 2007
    ..The present study compares the activity of an innovative 2% chlorhexidine gluconate (CHG)-impregnated preoperative skin preparation cloth (PC) with a standard application procedure with a 4% CHG surgical skin preparation (SP)...
  7. ncbi Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices
    Charles E Edmiston
    Division of Vascular Surgery, Medical College of Wisconsin, 9200 West Wisconsin Ave, Milwaukee, WI 53226, USA
    Am J Surg 192:344-54. 2006
    ..The present study investigated the activity of 6 antimicrobial agents against biofilm-forming and non-biofilm-forming strains of staphylococci adherent to the surface of selected biomedical devices...
  8. ncbi Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients
    Charles E Edmiston
    Division of Vascular Surgery, Medical College of Wisconsin, Milwaukee, WI, USA
    J Antimicrob Chemother 56:872-8. 2005
    ..The aim of the study was to analyse the susceptibility of unique and non-duplicate aerobic and anaerobic isolates from surgical patients to a novel des-F(6)-quinolone (garenoxacin) and other selected antimicrobial agents...
  9. ncbi Tissue and fluid penetration of garenoxacin in surgical patients
    Charles E Edmiston
    Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Surg Infect (Larchmt) 8:179-88. 2007
    ....
  10. ncbi In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections
    Charles E Edmiston
    Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Antimicrob Agents Chemother 48:1012-6. 2004
    ..Moxifloxacin exhibited good to excellent antimicrobial activity against most aerobic (90.8%) and anaerobic (97.1%) microorganisms, suggesting that it may be effective for the treatment of polymicrobial surgical infections...
  11. ncbi The importance of beta-lactamase resistance in surgical infections
    C E Edmiston
    Surgical Microbiology Research Laboratory, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Surg Infect (Larchmt) 2:S13-22. 2001
    ..Clinical use of these agents has been associated with low rates of resistance and new data suggest they may have a specific role in controlling the emergence and spread of nosocomial infections...
  12. ncbi Anaerobic infections in the surgical patient: microbial etiology and therapy
    Charles E Edmiston
    Divisions of Trauma and Critical Care, Medical College of Wisconsin, Milwaukee, WI, 53226, USA
    Clin Infect Dis 35:S112-8. 2002
    ..The failure to consider the anaerobic flora as a component in the etiology of mixed surgical infections is associated with a high rate of perioperative and therapeutic failures...
  13. ncbi Reducing the risk of surgical site infections: did we really think SCIP was going to lead us to the promised land?
    Charles E Edmiston
    Surgical Microbiology Research Laboratory, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Surg Infect (Larchmt) 12:169-77. 2011
    ..It is estimated that 750,000-1 million SSIs occur in the U.S. each year, utilizing 3.7 million extra hospital days and costing more than $1.6 billion in excess hospital charges...
  14. ncbi Molecular epidemiology of microbial contamination in the operating room environment: Is there a risk for infection?
    Charles E Edmiston
    Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Surgery 138:573-9; discussion 579-82. 2005
    ..Breaks in surgical technique, host contamination, or hematogenous seeding are suggested as causal factors in these infections. This study implicates contamination of the operating room air as an additional etiology of infection...
  15. ncbi Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates
    C E Edmiston
    Department of Surgery, Medical College of Wisconsin, Milwaukee 53226
    Diagn Microbiol Infect Dis 9:105-13. 1988
    ..The results demonstrate that all four compounds exhibited broad antimicrobial activity against facultative and obligate anaerobic surgical isolates from intraabdominal and soft tissue infections...
  16. ncbi Vancomycin resistance: when failure becomes an opportunity for leadership
    C E Edmiston
    Department of Surgery, Medical College of Wisconsin, Milwaukee 53226, USA
    Ann Pharmacother 30:680-2. 1996
    ..To discuss the emergence of the enterococci as significant nosocomial pathogens and reports of glycopeptide resistance as demonstrating the failure of healthcare professionals to limit the clinical impact of these organisms...
  17. ncbi Efficacy of preoperative decontamination of the oral cavity
    A N Summers
    Medical College of Wisconsin, Department of Surgery, Milwaukee, USA
    Plast Reconstr Surg 106:895-900; quiz 901. 2000
    ..Although none of the patients in this study developed an infection, recommendations are provided for standardized preoperative treatment of the oral cavity...
  18. ncbi Post-antibiotic effect in Bacteroides fragilis group
    D J Siverhus
    Department of Surgery, Medical College of Wisconsin, Milwaukee 53226
    Ann Clin Lab Sci 18:326-36. 1988
    ..fragilis group to anaerobe active beta-lactams produces a prolonged suppression in growth. In theory, a prolonged PAE could influence the dosage regimentation of selective antibiotics...
  19. ncbi Prostaglandins and modulation of small bowel myoelectric activity
    C T Frantzides
    Department of Surgery, Medical College of Wisconsin, Milwaukee 53226
    Am J Physiol 262:G488-97. 1992
    ..PGE2 has an inhibitory effect both on the spontaneous and PGF2 alpha-induced small intestinal myoelectric and contractile activity...
  20. ncbi Penetration of ciprofloxacin and fleroxacin into biliary tract
    C E Edmiston
    Department of Surgery, Medical College of Wisconsin, Milwaukee 53226, USA
    Antimicrob Agents Chemother 40:787-91. 1996
    ..5 and 8.6 micrograms/ml and 1.2 and 4.4 micrograms/ml, respectively. Both agents demonstrate rapid tissue penetration with persistence at levels appropriate for treatment of biliary pathogens...
  21. ncbi Fibrous ball: a new manifestation of chronic defibrillator and pacemaker infection
    G H Almassi
    Department of Surgery, Medical College of Wisconsin, Milwaukee 53226, USA
    Ann Thorac Surg 67:1782-3. 1999
    ..Complete explanation of the defibrillator and pacemaker was done in both patients. New devices were subsequently implanted...
  22. ncbi Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination?
    Charles E Edmiston
    Division of Vascular Surgery, Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
    J Am Coll Surg 203:481-9. 2006
    ....
  23. ncbi Microbiology of middle ear effusions from 292 patients undergoing tympanostomy tube placement for middle ear disease
    David M Poetker
    Division of Pediatric Otolaryngology, Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
    Int J Pediatr Otorhinolaryngol 69:799-804. 2005
    ..Future directions include using more specific techniques such as PCR to better understand the microbiology of middle ear effusions...
  24. ncbi Activity of antibacterial impregnated central venous catheters against Klebsiella pneumoniae
    Kaya Yorganci
    Hacettepe University, Faculty of Medicine, Department of General Surgery, Ankara, Turkey
    Intensive Care Med 28:438-42. 2002
    ..The aim of this study was to evaluate and compare the adherence, persistence and colonization of Klebsiella pneumoniae on catheter surfaces and also to assess bacteriostatic and bactericidal levels...
  25. ncbi The monkeypox virus outbreak: reflections from the frontlines
    Charles E Edmiston
    Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA
    Am J Infect Control 31:382-4. 2003
  26. ncbi Fungal biofilm formation on cochlear implant hardware after antibiotic-induced fungal overgrowth within the middle ear
    Ricardo Cristobal
    Department of Otolaryngology and Communication Sciences, University of Wisconsin, Milwaukee, Milwaukee, WI 53226-3596, USA
    Pediatr Infect Dis J 23:774-8. 2004
    ..After 6 weeks, a fungal (Candida) biofilm was demonstrated on the implant surface. In this clinical setting, an antimicrobial strategy using an oral antifungal to prevent fungal overgrowth is a possibility...
  27. ncbi Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE
    Byron R Griffith
    Division of Pharmaceutical Sciences and the National Drug Discovery Group, University of Wisconsin Madison, Madison, WI 53706, USA
    J Am Chem Soc 129:8150-5. 2007
    ....
  28. ncbi Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels?
    Charles E Edmiston
    Department of Surgery, Medical College of Winsconsin, Milwaukee, 53226, USA
    Surgery 136:738-47. 2004
    ..Perioperative surgical antibiotic prophylaxis requires that therapeutically effective drug concentrations be present in the tissues...
  29. ncbi Operative strategies in aortic graft infections: is complete graft excision always necessary?
    Joseph P Hart
    Division of Vascular Surgery, The Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Ann Vasc Surg 19:154-60. 2005
    ..We conclude that in certain high-risk patients who may not tolerate complete graft excision, local resection of infected graft segments may be preferable and leads to similar short- and long-term outcome...